Alzamend Neuro Inc (ALZN) vs Imunon, Inc. (IMNN)
A side-by-side comparison of Alzamend Neuro Inc and Imunon, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALZN
Alzamend Neuro Inc
$1.41HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
IMNN
Imunon, Inc.
$1.24HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALZN vs IMNN
growth of $100 · dividends reinvested · last 5yALZN -100.0% (-84.9%/yr)IMNN -99.6% (-66.5%/yr)IMNN compounded faster over this window
Log scale — wide-divergence pair
ALZN IMNN
ALZN vs IMNN: by the numbers
- •ALZN is the larger company ($5M vs $5M market cap).
Metrics side by side
Valuation
| Metric | ALZN | IMNN |
|---|---|---|
| P/B ratio | 0.92 | 1.24 |
Profitability
| Metric | ALZN | IMNN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -156.77% | -351.30% |
| ROIC | -156.69% | -126.69% |
Growth (annualized)
| Metric | ALZN | IMNN |
|---|---|---|
| Total return CAGR (5Y) | -79.14% | -63.83% |
Frequently asked
- How have ALZN and IMNN total returns compared?
- Over the past 5 years, ALZN delivered -79.14% and IMNN delivered -63.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.